Location and outcome of anticoagulant-associated intracerebral hemorrhage.

Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.87

Warfarin use leads to larger intracerebral hematomas. Neurology (2008) 1.43

Advances in the management of intracerebral hemorrhage. Nat Rev Neurol (2010) 1.28

Risk factors for intracerebral hemorrhage differ according to hemorrhage location. Neurology (2012) 1.06

Characterization of the brain injury, neurobehavioral profiles, and histopathology in a rat model of cerebellar hemorrhage. Exp Neurol (2010) 0.93

Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies. Lancet Neurol (2013) 0.83

The challenge of designing a treatment trial for warfarin-associated intracerebral hemorrhage. Stroke (2009) 0.82

Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice. Crit Care (2012) 0.78

Oral anticoagulant-associated intracerebral hemorrhage. J Neurol (2011) 0.77

Modifiable risk factors for intracerebral hemorrhage: study of anticoagulated patients. Can Fam Physician (2008) 0.76

Evidence-based medicine and the Cochrane Collaboration on trial. MedGenMed (2007) 0.76

Management of anticoagulant-related intracranial hemorrhage: an evidence-based review. Crit Care (2014) 0.76

The critical care management of spontaneous intracranial hemorrhage: a contemporary review. Crit Care (2016) 0.75

Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 12.92

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.87

Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55

Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24

Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13

Stroke in a biracial population: the excess burden of stroke among blacks. Stroke (2004) 4.83

Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol (2011) 4.61

Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke (2005) 3.67

Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology (2012) 3.62

An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60

Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke (2010) 3.56

Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke (2002) 3.43

Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40

National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke (2008) 3.40

Designing a message for public education regarding stroke: does FAST capture enough stroke? Stroke (2007) 3.34

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke (2015) 3.17

Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke (2005) 3.00

Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke (2010) 2.99

Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke (2004) 2.97

Methodology of the Interventional Management of Stroke III Trial. Int J Stroke (2008) 2.88

Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke (2013) 2.88

Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87

Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke (2011) 2.80

The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study. Stroke (2006) 2.56

Racial differences in the impact of elevated systolic blood pressure on stroke risk. JAMA Intern Med (2013) 2.55

US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke. Stroke (2009) 2.54

Trends in community knowledge of the warning signs and risk factors for stroke. JAMA (2003) 2.40

Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38

Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke (2002) 2.36

Perimesencephalic subarachnoid hemorrhage: incidence, risk factors, and outcome. J Stroke Cerebrovasc Dis (2007) 2.36

Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol (2010) 2.31

Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke (2005) 2.26

Individual patient data subgroup meta-analysis of surgery for spontaneous supratentorial intracerebral hemorrhage. Stroke (2012) 2.26

Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab (2006) 2.20

Modified constraint-induced therapy in chronic stroke: results of a single-blinded randomized controlled trial. Phys Ther (2008) 2.19

Intracranial hemorrhage associated with revascularization therapies. Stroke (2007) 2.08

Early reperfusion and clinical outcomes in patients with M2 occlusion: pooled analysis of the PROACT II, IMS, and IMS II studies. J Neurosurg (2014) 2.01

Analysis of the effectiveness and cost benefit of leukotriene modifiers in adults with asthma in the Ohio Medicaid population. J Manag Care Pharm (2006) 2.00

Community socioeconomic status and prehospital times in acute stroke and transient ischemic attack: do poorer patients have longer delays from 911 call to the emergency department? Stroke (2006) 2.00

Temporal trends in public awareness of stroke: warning signs, risk factors, and treatment. Stroke (2009) 1.86

Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass. Stroke (2011) 1.86

Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke (2002) 1.82

Stroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes. Stroke (2013) 1.80

The challenges of community-based research: the beauty shop stroke education project. Stroke (2008) 1.79

The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke (2008) 1.79

Racial variations in location and risk of intracerebral hemorrhage. Stroke (2005) 1.78

Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites. Stroke (2004) 1.78

Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial. Stroke (2012) 1.76